We are live on ! Find out more
BLAM

Bourne Lent Asset Management Portfolio holdings

AUM $289M
1-Year Est. Return 30.86%
This Fund
S&P 500
This Quarter Est. Return
+9.89%
1 Year Est. Return
+30.86%
3 Year Est. Return
+76.09%
5 Year Est. Return
+95.46%
10 Year Est. Return
+670.42%
AUM
$233M
AUM Growth
+$3.34M
Cap. Flow
-$13.5M
Cap. Flow %
-5.81%
Top 10 Hldgs %
71.03%
Holding
65
New
7
Increased
7
Reduced
23
Closed
2

Top Buys

Rank Stock Value
1
GLD icon
SPDR Gold Trust
GLD
+$383K
2
NVDA icon
NVIDIA
NVDA
+$226K
3
SYM icon
Symbotic
SYM
+$224K
4
BA icon
Boeing
BA
+$221K
5
RIO icon
Rio Tinto
RIO
+$214K

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$6.17M
2
ISRG icon
Intuitive Surgical
ISRG
+$1.46M
3
IDXX icon
Idexx Laboratories
IDXX
+$1.18M
4
TMP icon
Tompkins Financial
TMP
+$1.04M
5
T icon
AT&T
T
+$924K

Sector Composition

Rank Sector Weight
1 Technology 40.38%
2 Healthcare 30.59%
3 Communication Services 10.26%
4 Industrials 5.75%
5 Consumer Discretionary 4.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LLY icon
26
Eli Lilly
LLY
$1.06T
$1.47M 0.63%
4,026
– –
TMP icon
27
Tompkins Financial
TMP
$1.42B
$1.2M 0.51%
15,434
-13,000
-46% -$1.04M
PEP icon
28
PepsiCo
PEP
$190B
$1.02M 0.44%
5,625
– –
TSLA icon
29
Tesla
TSLA
$1.3T
$998K 0.43%
8,100
-4,500
-36% -$852K
TROW icon
30
T. Rowe Price
TROW
$24.3B
$977K 0.42%
8,957
– –
PEG icon
31
Public Service Enterprise Group
PEG
$37.7B
$927K 0.4%
15,122
– –
BSX icon
32
Boston Scientific
BSX
$71.5B
$822K 0.35%
17,769
+50
+0.3% +$2.17K
T icon
33
AT&T
T
$163B
$807K 0.35%
43,851
-51,600
-54% -$924K
GILD icon
34
Gilead Sciences
GILD
$165B
$737K 0.32%
8,580
+100
+1% +$7.92K
LOW icon
35
Lowe's Companies
LOW
$125B
$697K 0.3%
3,500
– –
MRK icon
36
Merck
MRK
$318B
$662K 0.28%
5,967
– –
MCHP icon
37
Microchip Technology
MCHP
$46B
$546K 0.23%
7,770
+40
+0.5% +$2.75K
PG icon
38
Procter & Gamble
PG
$339B
$529K 0.23%
3,491
– –
EOG icon
39
EOG Resources
EOG
$70.7B
$525K 0.22%
4,051
– –
CNP icon
40
CenterPoint Energy
CNP
$26.8B
$509K 0.22%
16,966
– –
HD icon
41
Home Depot
HD
$355B
$426K 0.18%
1,350
– –
VZ icon
42
Verizon
VZ
$196B
$411K 0.18%
10,419
– –
GLD icon
43
SPDR Gold Trust
GLD
$141B
$403K 0.17%
+2,375
New +$383K
XOM icon
44
ExxonMobil
XOM
$634B
$389K 0.17%
3,527
– –
ILMN icon
45
Illumina
ILMN
$28.4B
$366K 0.16%
1,861
-1,017
-35% -$211K
NVTA
46
DELISTED
Invitae Corporation
NVTA
$356K 0.15%
191,350
-12,450
-6% -$30.4K
SLB icon
47
SLB Ltd
SLB
$75B
$323K 0.14%
6,050
– –
INTU icon
48
Intuit
INTU
$89B
$313K 0.13%
805
+1
+0.1% +$397
INTC icon
49
Intel
INTC
$513B
$304K 0.13%
11,490
– –
ABT icon
50
Abbott
ABT
$187B
$282K 0.12%
2,568
– –
1
2
3

Similar funds

PIA
PineBridge Investments Asia Hong Kong $289M AUM
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
GIM
Goodlander Investment Management Dallas, Texas $289M AUM 225.62% 1-Year Est. Return
PSA
Plum Street Advisors New Orleans, Louisiana $289M AUM 17.28% 1-Year Est. Return
SI
Saxon Interests Houston, Texas $290M AUM 19.97% 1-Year Est. Return
FFA
Fairfield Financial Advisors Wellesley, Massachusetts $290M AUM 15.81% 1-Year Est. Return
OCM
Orion Capital Management Coronado, California $290M AUM 17.97% 1-Year Est. Return
ODFS
O'Donnell Financial Services San Rafael, California $290M AUM 15.6% 1-Year Est. Return

Bourne Lent Asset Management's Q4 2022 Portfolio in Review

As of Q4 2022, Bourne Lent Asset Management held 65 positions worth $233M, up 1.5% from $230M the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Bourne Lent Asset Management withdrew a net $13.5M in Q4 2022, closing 2 positions and reducing 23 holdings. Its most notable exit was Warner Bros, an estimated $261K position sold in full.

By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 39% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, Bourne Lent Asset Management opened a new position in SPDR Gold Trust worth $403K.

  • Bourne Lent Asset Management's largest Q4 2022 buy was SPDR Gold Trust: 2,375 shares worth $403K.
  • Bourne Lent Asset Management added most to Pacific Biosciences in Q4 2022, an estimated $62.9K increase.
  • Bourne Lent Asset Management's biggest Q4 2022 reduction was Bristol-Myers Squibb, cutting an estimated $6.17M.
  • Bourne Lent Asset Management fully exited Warner Bros in Q4 2022, selling an estimated $261K.
  • Bourne Lent Asset Management's ten largest holdings make up 71% of its $233M portfolio in Q4 2022.
  • Bourne Lent Asset Management opened 7 new positions and closed 2 in Q4 2022.
  • Bourne Lent Asset Management's portfolio value rose 1.5% quarter-over-quarter to $233M.

Based on Bourne Lent Asset Management's 13F filing for Q4 2022, filed 24 Jan 2023.